Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1/2 1

Status

Completed 10Unknown 3Terminated 3Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Non-Small-Cell Lung 381Breast Neoplasms 364Colorectal Neoplasms 238Stomach Neoplasms 218Carcinoma, Hepatocellular 155Lung Neoplasms 123Neoplasms 120Pancreatic Neoplasms 109Prostatic Neoplasms 100Neoplasm Metastasis 96Recurrence 95Rectal Neoplasms 95Ovarian Neoplasms 90Nasopharyngeal Carcinoma 88Esophageal Neoplasms 82Esophageal Squamous Cell Carcinoma 81Lymphoma, Large B-Cell, Diffuse 79Melanoma 75Small Cell Lung Carcinoma 71Uterine Cervical Neoplasms 70Lymphoma 70Leukemia, Myeloid, Acute 70Brain Neoplasms 69Sarcoma 68Head and Neck Neoplasms 68Squamous Cell Carcinoma of Head and Neck 67Multiple Myeloma 65Carcinoma, Renal Cell 63Triple Negative Breast Neoplasms 61Lymphoma, Non-Hodgkin 53

Interventions

talazoparib 1Radiosurgery 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Prostate Cancer Metastatic × Clear all
NCT06251492 2024-02-20

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Fudan University

Phase 2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04824937 2021-04-01

Telaglenastat + Talazoparib In Prostate Cancer

Massachusetts General Hospital

Phase 2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04603833 2021-02-21

A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Unknown
150 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡